Verification of consumers' experiences and perceptions of genetic discrimination and its impact on utilization of genetic testing

Genetics in Medicine

Volumn 11, Issue 3, 2009, Pages 193-201

  Barlow Stewart, Kristine ^a,b   Taylor, Sandra D ^c   Treloar, Susan A ^d   Stranger, Mark ^e   Otlowski, Margaret ^e  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b University of Sydney   (Australia)

^c CENTRAL QUEENSLAND UNIVERSITY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Genetic discrimination; Huntington disease; Inherited cancers; Law; Life insurance

Indexed keywords

ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONSUMER; DECISION MAKING; ETHICS; EXPERIENCE; FEMALE; FINANCIAL MANAGEMENT; GENETIC ANALYSIS; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEMOCHROMATOSIS; HUMAN; HUNTINGTON CHOREA; INCIDENCE; INHERITANCE; INTERVIEW; KIDNEY POLYCYSTIC DISEASE; MALE; PERCEPTION; PERSUASIVE COMMUNICATION; PRACTICE GUIDELINE; PRISON; WORKMAN COMPENSATION;

ADULT; AUSTRALIA; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; CONSUMER HEALTH INFORMATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC PRIVACY; GENETIC SCREENING; HEMOCHROMATOSIS; HUMANS; HUNTINGTON DISEASE; INSURANCE SELECTION BIAS; INSURANCE, LIFE; MALE; MIDDLE AGED; PERCEPTION; POLYCYSTIC KIDNEY DISEASES; PREJUDICE;

EID: 63449084638     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e318194ee75     Document Type: Article

References (63)

1. Taylor SD, Otlowski MF, Barlow-Stewart KK, Treloar SA, Stranger M, Chenoweth K. Investigating genetic discrimination in Australia: opportunities and challenges in the early stages. New Genet Soc 2004;23:225-239.
2. Barlow-Stewart K, Keays D. Genetic discrimination in Australia (2001). J Law Med 2004;8:250.
3. Taylor SD, Treloar SA, Barlow-Stewart KK, Stranger M, Otlowski M. Investigating perceptions and experiences of genetic discrimination. I. A large-scale survey of clinical genetic service consumers in Australia. Clin Genet 2008;74:20-30.
4. Taylor S, Treloar S, Barlow-Stewart K, et al. Investigating genetic discrimination in Australia: perceptions and experiences of clinical genetics service clients regarding coercion to test, insurance and employment. Aust J Emerg Techn Soc 2007;5:63. Available at: www.swinburne.edu.au/ajets.
5. Geller LN. Current developments in genetic discrimination. In: Alper JS, Ard C, Asch A, Beckwith J, Conrad P, Geller L, editors. The double-edged helix: social implications of genetics in a diverse society. Baltimore: Johns Hopkins University Press, 2002:267.
6. Geller LN, Alper JS, Billings PR, Barash CI, Beckwith J, Natowicz MR. Individual, family, and societal dimensions of genetic discrimination: a case study analysis. Sci Eng Ethics 1996;2:71-88.
7. Hall MA, McEwen JE, Barton JC, et al. Concerns in a primary care population about genetic discrimination by insurers. Gen Med 2005;7:311-316.
8. Low L, King S, Wilkie T. Genetic discrimination in life insurance: empirical evidence from a cross sectional survey of genetic support groups in the United Kingdom. BMJ 1998;317:1632-1635.
9. Hendricks A. Genetics, human rights and employment: American and European perspectives. Med Law 1997;16:557-565.
10. Wertz DC. Genetic discrimination-an overblown fear? Nat Rev Genet 2002;297:196-197.
11. Australian Law Reform Commission & Australian Health Ethics Committee of the National Health & Medical Research Council NHMRC (ALRC/AHEC/AHEC/AHEC), 2003. Essentially yours: the protection of Human Genetic Information in Australia. Available at: http://www.alrc.gov.au. Accessed July 2008.
12. Otlowski M, Taylor S, Barlow-Stewart K. Major study commencing into genetic discrimination in Australia. J Law Med 2002;10:41-48.
13. Otlowski M, Stranger M, Taylor S, et al. Practices and attitudes of Australian employers in relation to the use of genetic information: report of a national study. Comp Labor Law Policy J In press.
14. Otlowski M, Barlow-Stewart K, Taylor S, Stranger M, Treloar S. Investigating genetic discrimination in the Australian life insurance sector: the use of genetic test results in underwriting, 1999-2003. J Law Med 2007;I4:367-396.
15. Otlowski MF, Taylor SD, Barlow-Stewart KK, Stranger M, Treloar SA. The use of legal remedies in Australia for pursuing allegations of genetic discrimination: findings of an empirical study. Int J Discrim 2007;9:3.
16. Oxford Concise Dictionary. 6th ed. London: Oxford Univ Press, 1976.
17. Investment and Financial Services Association (IFSA). Available at: http://www.ifsa.com.au/index.aspx. Accessed August 2008.
18. Disability Discrimination Act (Cth) s 46. Available at: http://www.austlii. edu.au/au/legis/cth/consol-act/ddal992264/. Accessed May 2008.
19. Insurance Contracts Act 1984 (Cth), ss 13, 21. Available at; http://www. austlii.edu.au/au/legis/cth/consol-act/ical984220/. Accessed May 2008.
20. Human Rights and Equal Opportunity Commission (HREOC), 2005. Disability standards and guidelines: guidelines for providers of insurance and superannuation. Available at: http://www.hreoc.gov.au/disability-rights/ standards/ Insurance/insurance-adv.html. Accessed May 2008.
21. Investment and Financial Services Association (IFSA). Standard No 11.00 Genetic Testing, cll 10.1 and 10.3. Available at: http://www.ifsa.com.au. Accessed May 2008.
22. Otlowski M. Implications of genetic testing for Australian insurance law and practice. Centre for law and genetics, 2001. Occasional Paper No. 1.
23. Otlowski M. Resolving the conundrum: should insurers be entitled to access genetic test information? Ins Law J 2000;11:193-215.
24. Scheuner MT. Online management of breast diseases. 1997. Available at: http://www.breastdiseases.com/genebr.htm. Accessed March 2008.
25. Australian Commonwealth Department of Health and Ageing, Private Health Insurance Administration Council. Available at: http://www.phiac.gov.au/. Accessed March 2008.
26. Lynch E, Doherty RJ, Gaff CL, Macrae FA, Lindeman GJ. Cancer in the family and genetic testing: implications for life insurance. Med J Aust 2003;179:480-483.
27. Swiss Re sigma No 3, 2008. World insurance in 2007: emerging markets leading the way. Available at: http://www.swissre.com/. Accessed August 2008.
28. American Council of Life Insurers, 2007. Life insurance fact book. Available at: http://www.acli.com. Accessed August 2008.
29. Genetic Information Nondiscrimination Act, S. 358 (G1NA). Available at: http://www.govtrack.us/congress/bilt.xpd?bill=sl10-358. Accessed April 2008.
30. Hudson KJ, Holohan MK, Collins F. Keeping pace with the times-the genetics Nondiscrimination Act of 2008. N Engl J Med 2008;358:2661-2663.
31. National Health and Medical Research Council. Familial aspects of cancer: a guide to clinical practice. 1999. National Health and Medical Research Council. Available at: http://www.hmrc.gov.au/publications/synopses/-files/cp67. pdf. Accessed January 30, 2009.
32. Antoniou A, Pharoah PD, Narad S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-1130.
33. Chen S, Iversen ES, Friebel T, et al. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol 2006;24:863-871.
34. Antoniou A, Pharaoh P, Easton D, Evans DG. BRCA1 and BRCA2 cancer risks. J Clin Oncol 2006;24:3312-3313.
35. Spiteri G. Genetic testing and its implications for Australian insurance law. James Cook Uni Law Rev 2000: 96.
36. Antoniou A, Spurdle A, Sinilnikova OM, et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 2008;82:937-948.
37. U.S.-Venezuela Collaborative Research Project; Wexler NS, Lorimer J, Porter J, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Nat Acad Sci USA 2004;101:3498-3503.
38. Brinkman R, Mezei MM, Theilmann J, Almqvist E, Hayden MR. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am J Hum Genet 1997;60:1202-1210.
39. Bertario L, Russo A, Sala P, et al; Hereditary Colorectal Tumor Registry. Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol 2003;21:1698-1707.
40. Malone K, Daling J, Neal C, et al. Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer 2000;88:1393-1402.
41. Moller P, Evans D, Reis M, et al. Surveillance for familial breast cancer: differences in outcome according to BRCA mutation status. Int J Cancer 2007;121:1017-1020.
42. Association of British Insurers. Available at: http://www.abi.org.United Kingdom/. Accessed February 2008.
43. HM Government and the Association of British Insurers, Concordat and Moratorium on Genetics and Insurance, March 2005.
44. Joly Y, Knoppers BM, Godard B. Genetic information and life insurance: a 'real' risk? Eur J Hum Genet 2003;11:561-564.
45. Association of British Insurers (ABI). ABI Genetic Testing and Insurance, Compliance Report and Data Analysis for 2003. Available at: http://www.abi.org.uk. Accessed May 2008.
46. Hallowell N, Ardern-Jones A, Eeles R, et al. Men's decision-making about predictive BRCA1/2 testing: the role of the family. J Gen Couns 2005;14:207-217.
47. Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B. Factors associated with clinical BRCA1/2 testing. Cancer Epidemiol Biomarkers 2000;9:1251-1254.
48. Regenauer A, Schmidtke J. Genetics. Basis for medicine in the 21st century; genetic testing and insurance - a global view. Munich Reinsurance Co., 1998. Munchener Ruckvericherungs-Gesellschaft, Munchen.
49. Investment and Financial Services Association, Submission G049, 14 January 2002 to the Australian Law Reform Commission & Australian Health Ethics Committee of the National Health & Medical Research Council NHMRC (ALRC/AHEC), 2003. Essentially yours: the protection of Human Genetic Information in Australia 2003. Available at: http://www.alrc.gov.au. Accessed March 2008.
50. Australian Law Reform Commission & Australian Health Ethics Committee of the National Health & Medical Research Council NHMRC (ALRC/AHEC), 2003. Essentially yours: the protection of Human Genetic Information in Australia. Recommendations 27-10-27-11 Available at: http://www.alrc. gov.au. Accessed March 2008.
51. Centre for Genetics Education (GCE), 2003. 'Genetic Information and Life Insurance Products in Australia.' Available at: http://www.genetics.com.au/pdf/ pubs/lifeinsurance.pdf. Accessed March 2008.
52. Genetic Interest Group (GIG). The template project. Availble at: http://www.gig.org.uk. Accessed April 2008.
53. Barlow-Stewart K, Taylor S, Otlowski M. Knowing your genes. In: Wilson S, Meagher G, Gibson R, et al., editors. Australian social attitudes-the first report. Sydney: University of New South Wales Press Ltd., 2005:204-219.
54. Rothstein M. Genetics and life insurance. Medical underwriting and social policy. MA: MIT Press, 2004. ISBN 026218236X, 9780262182362.
55. Radetzki M, Radetzki M, Juth N. Genes and insurance. Ethical, legal and economic issues. UK: Cambridge University Press, 2004. ISBN 0521830907.
56. Rothstein M, Knoppers B. Legal aspects of genetics, work and insurance in North America and Europe. Eur J Health Law 1996;3:143-161.
57. Parthasarthy S. Regulating risk: defining genetic privacy in the United States and Britain. Sci Technol Hum Values 2004;29:332-352.
58. Ian Hammond Consulting Ltd for Department of Health and Department of Trade and Industry, 2008. Light touch review of the Human Genetics Commission. Final report February 2008. Available at: http://www.dh.gov.uk/en/ Pubhcaticrisandstausncs/Pubucations/PuplicationsPolicyAndGuidanceDH-084690. Accesed May 24, 2008.
59. Australian Law Reform Commission &Australian Health Ethics Committee of the National Health & Medical Research Council NHMRC (ALRC/ AHEC), 2003. Essentially yours: the protection of Human Genetic Information in Australia. Recommendation 5-1. Available at: http://www.alrc.gov.au. Accessed March 2008.
60. Lemmens T. Private parties, public duties? The shifting tole of insurance companies in the genetics era. In: Thompson A, Chadwick R, editors. Genetic information: acquisition, access and control. New York: Kluwer Academic/ Plenum Publishers, 1999:31-39.
61. Investment and Financial Services Association, Submission G244,19 December 2002 to the Australian Law Reform Commission & Australian Health Ethics Committee of the National Health & Medical Research Council NHMRC (ALRC/AHEC), 2003. Essentially yours: the protection of Human Genetic Information in Australia. Available at: http://www.alrc.gov.au. Accessed March 2008.
62. Institute of Actuaries of Australia, Submission G105, 7 March 2002 to the Australian Law Reform Commission & Australian Health Ethics Committee of the National Health & Medical Research Council NHMRC (ALRC/AHEC), 2003. Essentially yours: the protection of Human Genetic Information in Australia. Available at: http://www.alrc.gov.au. Accessed March 2008.
63. Bombard Y, Pensiner E, Decolongon J, et al. Managing genetic discrimination: strategies used by individuals found to have the Huntington disease mutation. Clin Genet 2007;71:220-231.